Effects of empagliflozin on markers of calcium and phosphate homeostasis in patients with type 2 diabetes – Data from a randomized, placebo-controlled study

por Rau, Matthias, Thiele, Kirsten, Hartmann, Niels-Ulrik Korbinian, Möllmann, Julia, Wied, Stephanie, Hohl, Mathias, Marx, Nikolaus, Lehrke, Michael
Publicado 2022

The Role of Vitamin D(3) as an Independent Predicting Marker for One-Year Mortality in Patients with Acute Heart Failure

por Thiele, Kirsten, Cornelissen, Anne, Florescu, Roberta, Kneizeh, Kinan, Brandenburg, Vincent Matthias, Witte, Klaus, Marx, Nikolaus, Schuh, Alexander, Stöhr, Robert
Publicado 2022

Cardiopulmonary work up of patients with and without fatigue 6 months after COVID-19

por Thiele, Kirsten, Balfanz, Paul, Müller, Tobias, Hartmann, Bojan, Spiesshoefer, Jens, Grebe, Julian, Müller-Wieland, Dirk, Marx, Nikolaus, Dreher, Michael, Daher, Ayham
Publicado 2022

Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized c...

por Rau, Matthias, Thiele, Kirsten, Hartmann, Niels-Ulrik Korbinian, Schuh, Alexander, Altiok, Ertunc, Möllmann, Julia, Keszei, András P., Böhm, Michael, Marx, Nikolaus, Lehrke, Michael
Publicado 2021

Empagliflozin reduces markers of acute kidney injury in patients with acute decompensated heart failure

por Thiele, Kirsten, Rau, Matthias, Hartmann, Niels‐Ulrik Korbinian, Möller, Marcus, Möllmann, Julia, Jankowski, Joachim, Keszei, András P., Böhm, Michael, Floege, Jürgen, Marx, Nikolaus, Lehrke, Michael
Publicado 2022

Human and mouse non‐targeted metabolomics identify 1,5‐anhydroglucitol as SGLT2‐dependent glycemic marker

por Kappel, Ben A., Moellmann, Julia, Thiele, Kirsten, Rau, Matthias, Artati, Anna, Adamski, Jerzy, Ghesquiere, Bart, Schuett, Katharina, Romeo, Francesco, Stoehr, Robert, Marx, Nikolaus, Federici, Massimo, Lehrke, Michael
Publicado 2021